MYOMAR MOLECULAR
Myomar Molecular is developing a diagnostic tool to identify early stages of muscle atrophy. this technology will be used by physiotherapists and medical doctors to access therapy approaches, reduce hospitalization time, and analyze recovery progress.
MYOMAR MOLECULAR
Industry:
Health Care Health Diagnostics Medical
Status:
Active
Total Funding:
15 K USD
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
EyeNetra
EyeNetra is a developer of an eye diagnostics platform used to measure the correction of users' vision through smartphone-based technology.
Current Employees Featured
Founder
Investors List
Ready2Launch
Ready2Launch investment in Pre Seed Round - Myomar Molecular